Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.23 USD | -0.12% | +1.23% | -44.87% |
Apr. 30 | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |